Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report

Induction treatment with rituximab—an anti-CD20 monoclonal antibody—may increase the risk of varicella-zoster virus (VZV) reactivation in patients with antineutrophil-cytoplasmic-antibody-associated vasculitis (AAV). Our case report shows VZV reactivation following rituximab treatment in AAV patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ho-Hsiang, Chen, Hsuan, Lin, Wei-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759945/
https://www.ncbi.nlm.nih.gov/pubmed/36540838
http://dx.doi.org/10.1093/omcr/omac134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759945/
https://www.ncbi.nlm.nih.gov/pubmed/36540838
http://dx.doi.org/10.1093/omcr/omac134

Ejemplares similares